Wendy Johnson

Biography

  Ms. Johnson has served as a member of the Company’s board of directors since May 2014 and served as interim COO from September 2014 to January 2017. From 2005 to January 2014 Ms. Johnson served as a Venture Partner at ProQuest Investments, a venture capital firm. From November 2006 until January 2014, Ms. Johnson served as the President and Chief Executive Officer of Aires Pharmaceuticals, a ProQuest portfolio company. Prior to joining ProQuest, she served as Senior Vice President, Corporate Development, at Salmedix Inc., and has held senior business and corporate development positions at WomenFirst Healthcare, Prizm Pharmaceuticals (Selective Genetics Inc.), Cytel Corp., Synbiotics Corp., and Murex Corp. (Cambridge U.K.). Additionally, Ms. Johnson served as Assistant Director for the Center for Devices and Radiological Health at the U.S. Food and Drug Administration. Ms. Johnson received an M.B.A. from Loyola University, an M.S. in Clinical Microbiology from the Hahnemann Medical School and a B.S. in Microbiology from the University of Maryland.

Research Interest

Pharma, Clinical research, Pharmaceutical sciences